ClassID:

20210

A61K31/11 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Aldehydes

Recent Application in this class:
#301
20170049678
2017-02-23

Combination of a hyaluronic acid and of a sulphated polysaccharide

#302
20170042867
2017-02-16

THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF

#303
20170042866
2017-02-16

Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof

#304
20170042865
2017-02-16

Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof

#305
20170042834
2017-02-16

ION CHANNEL ACTIVATORS AND METHODS OF USE

#306
20170042161
2017-02-16

Biocide compositions based on calcium fluoride as well as uses thereof

#307
20170035758
2017-02-09

Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi

#308
20170006864
2017-01-12

Antifungal composition

#309
20170000762
2017-01-05

Anti-microbial composition

#310
20160375205
2016-12-29

Nasal Inhaler Band

#311
20160374979
2016-12-29

Method of Treatment of Alopecia with Monoterpenoids

#312
20160367606
2016-12-22

COMPOSITION HAVING HYDROLYZED COLLAGEN AND MANUKA HONEY

#313
20160367499
2016-12-22

PROMOTION OF LYMPHATIC FUNCTION

#314
20160361273
2016-12-15

Antimicrobials and methods of use thereof for wound healing

#315
20160361272
2016-12-15

EDIBLE COMPOSITION INCLUDING SAFRANAL, CROCIN, PICROCROCIN AND A VITAMIN B COMPLEX FOR TREATING THE INITIAL PHASE OF DEPRESSION

#316
20160346180
2016-12-01

Compositions for use in treatment of hyperpigmentation and methods of use thereof

#317
20160339058
2016-11-24

METHODS AND COMPOSITIONS FOR USING CINNAMALDEHYDE AND ZINC FOR WEIGHT MANAGEMENT

#318
20160317500
2016-11-03

Use of biotin and natural essential oils for bovine animals for the prevention and treatment of ketosis

#319
20160317470
2016-11-03

Agent for inhibiting odor of pyrazine derivatives

#320
20160317469
2016-11-03

Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same

#321
20160310469
2016-10-27

NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY

#322
20160310400
2016-10-27

METHOD FOR PREPARING LIPOSOMES OF RETINALDEHYDE OR OTHER PRECURSORS OF RETINOIC ACID AND PRODUCT THUS OBTAINED

#323
20160303055
2016-10-20

Methods and compositions for increasing energy expenditure using cinnamaldehyde

#324
20160296494
2016-10-13

Dihydroorotic and acid dehydrogenase inhibitor

#325
20160296479
2016-10-13

Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections

#326
20160296478
2016-10-13

THERAPEUTIC REGIMENS AND METHODS FOR IMPROVING VISUAL FUNCTION IN VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY

#327
20160237502
2016-08-18

MARKERS FOR LIPID METABOLISM

#328
20160220722
2016-08-04

Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use

#329
20160220627
2016-08-04

Extracts of and uses thereof

#330
20160213702
2016-07-28

Glycan therapeutics and related methods thereof

#331
20160206654
2016-07-21

METHODS AND FEED SUPPLEMENTS FOR LIVESTOCK

#332
20160206542
2016-07-21

Cosmetic or dermatological compositions combining cosmetiques retinaldehyde and glycylglycine oleamide and the cosmetic or dermatological uses thereof

#333
20160199490
2016-07-14

Trans carotenoids, their synthesis, formulation and uses

#334
20160199318
2016-07-14

Anti-Viral Compound and Composition

#335
20160194266
2016-07-07

Pharmaceutical compound for the prevention and treatment

#336
20160184298
2016-06-30

INHIBITORS AND ENHANCERS OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE 2B (UGT2B)

#337
20160184289
2016-06-30

Compositions containing aromatic aldehydes and their use in treatments

#338
20160184249
2016-06-30

Traditional Chinese medicine composition

#339
20160175264
2016-06-23

Compositions and methods using P-anisaldehyde

#340
20160168116
2016-06-16

IRE-1α inhibitors

#341
20160151304
2016-06-02

Compositions and methods using cuminaldehyde

#342
20160151303
2016-06-02

Compositions and methods using tiglic aldehyde

#343
20160143976
2016-05-26

Traditional chinese medicine composition, and preparation and application thereof

#344
20160143917
2016-05-26

COMPOSITIONS AND METHODS FOR MODULATING HIV ACTIVATION

#345
20160136109
2016-05-19

COMPOSITIONS FOR TISSUE STABILIZATION

#346
20160129023
2016-05-12

Bicyclic aryl sphingosine 1-phosphate analogs

#347
20160128933
2016-05-12

Therapeutic Methods and Compositions

#348
20160106776
2016-04-21

FEED SUPPLEMENT AND ITS USE

#349
20160106724
2016-04-21

Human therapeutic agents

#350
20160106722
2016-04-21

HUMAN THERAPEUTIC AGENTS

#351
20160106687
2016-04-21

HUMAN THERAPEUTIC AGENTS

#352
20160106668
2016-04-21

Cholecystokinin secretion-promoting composition

#353
20160089342
2016-03-31

METHOD OF INHIBITING XANTHINE OXIDASE ACTIVITY IN A CELL

#354
20160089313
2016-03-31

Method for searching for malodor control agent, malodor control agent, and malodor control method

#355
20160051604
2016-02-25

Seaweed extracts, unsaturated aldehydes, and methods of treatment

#356
20160051536
2016-02-25

COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS

#357
20160045453
2016-02-18

Stabilized mutant opsin proteins

#358
20160030437
2016-02-04

Tau aggregation inhibitor

#359
20160029625
2016-02-04

Arthropod control composition, formulation, and method

#360
20160022605
2016-01-28

METHODS FOR REDUCING MICROSATELLITE INSTABILITY INDUCED BY CHEMOTHERAPY AND METHODS FOR SCREENING ANTIOXIDANTS THAT SUPPRESS DRUG-INDUCED MICROSATELLITE INSTABILITY WHILE ENHANCING THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS

#361
20160015555
2016-01-21

Tissue crosslinking for treatment of snoring and obstructive sleep apnea

#362
20160008419
2016-01-14

Methods and Compositions for the Prevention and Treatment of Parasitic Disease

#363
20160002279
2016-01-07

Anti-cancer compounds from invasive salvinias and methods of treating cancer

#364
20160000786
2016-01-07

Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi

#365
20150366819
2015-12-24

COMPOSITIONS AND METHODS FOR TREATING HOOF DISEASES

#366
20150361020
2015-12-17

4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease

#367
20150353471
2015-12-10

Xanthine oxidase inhibitors and methods of use

#368
20150335671
2015-11-26

SMALL-MOLECULE BINDING SITE ON PRO-APOPTOTIC BAX REGULATES INHIBITION OF BAX ACTIVITY

#369
20150335610
2015-11-26

PDK4 INHIBITOR AND USE THEREOF

#370
20150327583
2015-11-19

Sensation masking composition

#371
20150305367
2015-10-29

FROZEN CONFECTION

#372
20150297753
2015-10-22

Compositions for delivery of oral comfort sensations

#373
20150272907
2015-10-01

Methods and compositions for modifying sensorial perception

#374
20150258079
2015-09-17

Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis

#375
20150238605
2015-08-27

Semifluorinated alkane compositions

#376
20150203445
2015-07-23

Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex

#377
20150164941
2015-06-18

Keratolytic composition with anti-allergic anti-inflammatory properties

#378
20150164823
2015-06-18

CHOLECYSTOKININ SECRETION-PROMOTING COMPOSITION

#379
20150140125
2015-05-21

SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS

#380
20150139918
2015-05-21

Mixtures having improved cooling effect

#381
20150110731
2015-04-23

Inhibitor of odor caused by Furaneol

#382
20150104439
2015-04-16

Pharmaceutical removal of neuronal extensions from a degenerating disc

#383
20150099015
2015-04-09

Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical

#384
20150051294
2015-02-19

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#385
20150044278
2015-02-12

Methods and compositions for the treatment of proliferative disorders

#386
20150038576
2015-02-05

COMPOSITIONS AND THEIR USE FOR SMOKING CESSATION AND OTHER TREATMENTS

#387
20150011649
2015-01-08

Methods of treating infectious diseases

#388
20150005389
2015-01-01

Small molecule xanthine oxidase inhibitors and methods of use

#389
20150004699
2015-01-01

Small molecule xanthine oxidase inhibitors and methods of use

#390
20140378552
2014-12-25

Small molecule xanthine oxidase inhibitors and methods of use

#391
20140378530
2014-12-25

Retinaldehyde mimetics and inhibitors of retinaldehyde dehydrogenase I in the treatment of disorders

#392
20140378478
2014-12-25

Small molecule xanthine oxidase inhibitors and methods of use

#393
20140364391
2014-12-11

Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

#394
20140363395
2014-12-11

Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

#395
20140343167
2014-11-20

Use of citral for treating focal segmental glomerulosclerosis

#396
20140336205
2014-11-13

Small molecule xanthine oxidase inhibitors and methods of use

#397
20140336204
2014-11-13

Methods of inhibiting xanthine oxidase activity in a cell

#398
20140330005
2014-11-06

Polysaccharide therapeutic conjugates

#399
20140329909
2014-11-06

Small molecule xanthine oxidase inhibitors and methods of use

#400
20140328902
2014-11-06

Antimicrobials and methods of use thereof for wound healing

#401
20140309190
2014-10-16

Bicyclic aryl sphingosine 1-phosphate analogs

#402
20140302169
2014-10-09

Method of treating ocular disorders

#403
20140301961
2014-10-09

COMPOUNDS WITH ANTI-AGING ACTIVITIES

#404
20140271879
2014-09-18

FINE DRY PARTICULATE RETINOID ACTIVE AGENT COMPOSITIONS AND TOPICAL FORMULATIONS INCLUDING THE SAME

#405
20140256795
2014-09-11

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#406
20140249209
2014-09-04

Methods for the treatment and prevention of liver disease

#407
20140243378
2014-08-28

Compounds and methods for the treatment of muscular disease, and related screening methods

#408
20140221426
2014-08-07

Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactivities

#409
20140220109
2014-08-07

NOVEL COCHLEATE FORMULATIONS

#410
20140163045
2014-06-12

Small molecule xanthine oxidase inhibitors and methods of use

#411
20140121646
2014-05-01

Nutrient Absorption Barrier And Delivery Method

#412
20140105952
2014-04-17

Carbonyl containing compounds for controlling and repelling populations

#413
20140088185
2014-03-27

METHOD OF TREATING DIGESTIVE UPSETS BY BUCCAL ADMINISTRATION OF BOTANICAL DERIVATIVES

#414
20140086909
2014-03-27

Methods and compositions for the treatment of proliferative disorders

#415
20140080832
2014-03-20

IRE-1α inhibitors

#416
20140057992
2014-02-27

Controlled activation of the reuterin-production machinery of

#417
20140056983
2014-02-27

FOOD ADDITIVE FOR RUMINANTS BASED ON EUGENOL AND CINNAMALDEHYDE

#418
20140045692
2014-02-13

Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic

#419
20140037555
2014-02-06

Process for oral care material taste and/or odor improvement

#420
20140031377
2014-01-30

Multicomponent crystalline system of rosuvastatin calcium salt and vanillin

#421
20140004062
2014-01-02

COMPOSITION INCLUDING 3-BROMO-4,5-DIHYDROXYBENZALDEHYDE COMPOUND AS EFFECTIVE COMPONENT FOR PROTECTING AND TREATING SKIN CELL AGANIST ULTRAVIOLET

#422
20130331323
2013-12-12

GLP-1 potentiators from hedychium coronarium and their applications

#423
20130324597
2013-12-05

PHARMACEUTICAL COMPOSITION COMPRISING TRANS-CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS

#424
20130310463
2013-11-21

Aromatase activator

#425
20130289103
2013-10-31

Anti-microbial composition

#426
20130289005
2013-10-31

Acne vulgaris treatment regimen

#427
20130281411
2013-10-24

COMPOSITIONS FOR TREATING INFLAMMATORY DERMATOLOGICAL DISEASES AND CONDITIONS AND METHODS OF USE THEREOF

#428
20130274231
2013-10-17

Compositions for use in treatment of dermatological diseases and conditions

#429
20130261191
2013-10-03

USE OF ESSENTIAL OIL COMPOUNDS AS HISTOMONASTAT

#430
20130216492
2013-08-22

Method for searching for malodor control agent, malodor control agent, and malodor control method

#431
20130210927
2013-08-15

Method of administering a pheromone composition to an animal to modify the animals behavior over an extended period of time

#432
20130210775
2013-08-15

AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES

#433
20130196950
2013-08-01

Retinoid replacements and opsin agonists and methods for the use thereof

#434
20130172425
2013-07-04

Compositions and methods for treating hoof diseases

#435
20130172387
2013-07-04

Method and composition for prolonging analgesic effect of local anesthetic

#436
20130150443
2013-06-13

Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them

#437
20130149362
2013-06-13

TREATMENT PRODUCT AND METHOD

#438
20130131121
2013-05-23

ANTI-VIRAL AGENT

#439
20130129637
2013-05-23

Method for producing reservoir layer for hoof treatment and reservoir layer

#440
20130087155
2013-04-11

Tissue crosslinking for treatment of snoring and obstructive sleep apnea

#441
20130072569
2013-03-21

RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF

#442
20130072568
2013-03-21

Retinoid replacements and opsin agonists and methods for the use thereof

#443
20130059869
2013-03-07

METHODS AND COMPOSITIONS FOR TREATING DISORDERS

#444
20130035359
2013-02-07

Compositions containing aromatic aldehydes and their use in treatments

#445
20130012475
2013-01-10

Cosmetic and pharmaceutical composition comprising N-acetylglucosamine-6-phosphate

#446
20120329874
2012-12-27

Synergetic composition comprising flavouring substances and organic acids and use thereof

#447
20120329757
2012-12-27

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#448
20120323211
2012-12-20

Coated balloons for blood vessel stabilization

#449
20120322891
2012-12-20

Retinoid replacements and opsin agonists and methods for the use thereof

#450
20120309848
2012-12-06

Uses of nonenal

#451
20120295939
2012-11-22

ANTI-VIRAL AGENT

#452
20120294901
2012-11-22

NOVEL COCHLEATE FORMULATIONS

#453
20120277178
2012-11-01

Compositions and methods for treating fragile X premutation RVGG repeats-mediated toxicity

#454
20120269901
2012-10-25

Methods and Compounds Useful to Induce Apoptosis in Cancer Cells

#455
20120190753
2012-07-26

Compositions containing aromatic aldehydes and their use in treatments

#456
20120190649
2012-07-26

Bicyclic aryl sphingosine 1-phosphate analogs

#457
20120183498
2012-07-19

Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

#458
20120164249
2012-06-28

Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof

#459
20120157546
2012-06-21

Compositions containing aromatic aldehydes and their use in treatments

#460
20120148690
2012-06-14

SKIN BARRIER FUNCTION RECOVERY ACCELERATOR

#461
20120135091
2012-05-31

METHODS AND COMPOSITIONS FOR ENHANCING LIFESPAN INVOLVING SIRTUIN-MODULATING COMPOUNDS AND CHALCOGENIDES

#462
20120108556
2012-05-03

METHODS AND DOSAGE FORMS FOR THE TREATMENT OF HUMAN CANCERS

#463
20120095099
2012-04-19

Trans carotenoids, their synthesis, formulation and uses

#464
20120093952
2012-04-19

USE OF ESSENTIAL OIL COMPOUNDS AS HISTOMONASTAT

#465
20120077875
2012-03-29

Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections

#466
20120070422
2012-03-22

Method of treating ocular disorders

#467
20120046556
2012-02-23

Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms

#468
20120046367
2012-02-23

ESSENTIAL OIL COMPOSITION WITH ANTI-FREE RADICAL ABILITY

#469
20120041073
2012-02-16

Stabilized mutant opsin proteins

#470
20120022425
2012-01-26

Alleviate back pain with lactic acid inhibitors

#471
20120009255
2012-01-12

METHODS OF TREATING INFECTIOUS DISEASES

#472
20110318434
2011-12-29

Acne vulgaris treatment regimen

#473
20110281949
2011-11-17

METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE AND MODULATING TRANSIENT RECEPTOR POTENTIAL CHANNELS

#474
20110257266
2011-10-20

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

#475
20110236481
2011-09-29

Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity

#476
20110230560
2011-09-22

Synergetic composition comprising flavouring substances and organic acids and use thereof

#477
20110224298
2011-09-15

DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

#478
20110218245
2011-09-08

Use of compounds to inhibit 5 α-reductase enzyme activity, and pharmaceutical and cosmetic compostions containing them

#479
20110189212
2011-08-04

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#480
20110189112
2011-08-04

Additives for chlorine dioxide-containing compositions

#481
20110172185
2011-07-14

Therapeutic drug for adult T-cell leukemia

#482
20110136918
2011-06-09

Methods of treating infectious diseases

#483
20110112123
2011-05-12

Compositions for intratumoral administration

#484
20110111057
2011-05-12

Methods and compounds useful to induce apoptosis in cancer cells

#485
20110098362
2011-04-28

Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization

#486
20110098261
2011-04-28

TRITERPENOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS

#487
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#488
20110065162
2011-03-17

IRE-1α inhibitors

#489
20110064864
2011-03-17

Food additive for ruminants based on eugenol and cinnamaldehyde

#490
20110052727
2011-03-03

Anti Influenza Nutritional Supplements

#491
20110046234
2011-02-24

Retinaldehyde in the treatment of obesity, diabetes and other conditions

#492
20110009955
2011-01-13

Compounds and method for coating surfaces in a hemocompatible manner

#493
20110002859
2011-01-06

CHEWING GUM CONTAINING EUCALYPTUS EXTRACT

#494
20100310494
2010-12-09

Styrax Benzoin Rejuvenating Cosmetic Preparation

#495
20100249244
2010-09-30

Methods and compositions for treating dermatological diseases and conditions

#496
20100249165
2010-09-30

PDZ DOMAIN MODULATORS

#497
20100234454
2010-09-16

TREATMENT OF CNIDARIA INTOXICATION

#498
20100216891
2010-08-26

AROMATIC ANTIHYPERTENSIVE AGENT, AND METHOD FOR LOWERING BLOOD PRESSURE IN MAMMALS

#499
20100190846
2010-07-29

MICROBICIDAL AGENT AND MICROBICIDAL COMPOSITION

#500
20100190832
2010-07-29

Mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and structural templates

#501
20100189818
2010-07-29

Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical

#502
20100189817
2010-07-29

Treating glaucoma

#503
20100178364
2010-07-15

Dietary supplements against latent foreign DNA

#504
20100158887
2010-06-24

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

#505
20100137595
2010-06-03

VAGINAL ODORANTS

#506
20100137451
2010-06-03

Compositions and methods for treating hoof diseases

#507
20100135966
2010-06-03

AGENTS FOR TREATING FLAVIVIRIDAE INFECTIONS

#508
20100121083
2010-05-13

ANTI-VIRAL AGENT

#509
20100119605
2010-05-13

COMPOSITIONS FOR TISSUE STABILIZATION

#510
20100093869
2010-04-15

Sensation masking composition

#511
20100069344
2010-03-18

SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS

#512
20100056621
2010-03-04

Agonists of a bitter taste receptor and uses thereof

#513
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#514
20100040594
2010-02-18

Formulations for nonsurgical exogenous crosslink therapy

#515
20100028464
2010-02-04

USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY

#516
20100004156
2010-01-07

Small Compounds That Correct Protein Misfolding and Uses Thereof

#517
20090324754
2009-12-31

EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF

#518
20090304656
2009-12-10

Controlled activation of the reuterin-production machinery of

#519
20090291919
2009-11-26

Compositions and Methods for Treating or Preventing Ophthalmic Light Toxicity

#520
20090258098
2009-10-15

PENETRATING CARRIER, ANTIFUNGAL COMPOSITION USING THE SAME AND METHOD FOR TREATMENT OF DERMATOPHYTE INFECTIONS

#521
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#522
20090186893
2009-07-23

IRE-1α inhibitors

#523
20090156686
2009-06-18

Composition containing higher fatty acid derivative and foods and drinks

#524
20090148541
2009-06-11

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEBORRHEA

#525
20090143377
2009-06-04

Methods and compositions for treating disorders

#526
20090092684
2009-04-09

Small molecule antagonists of Bcl-2 family proteins

#527
20090087417
2009-04-02

METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS

#528
20090082445
2009-03-26

GOSSYPOL CO-CRYSTALS AND THE USE THEREOF

#529
20090082424
2009-03-26

SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS

#530
20090076136
2009-03-19

THERAPEUTIC AGENT

#531
20090074708
2009-03-19

Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)

#532
20090047342
2009-02-19

Methods of treating infectious diseases

#533
20090030088
2009-01-29

Therapeutic benefits of gossypol, 6-methoxy gossypol, and 6,6'-dimothxy gossypol

#534
20090030055
2009-01-29

PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds

#535
20090028904
2009-01-29

Novel cochleate formulations

#536
20090018211
2009-01-15

Method for inhibiting of COX2 and inflammation with phenolic aldehydes

#537
20090012128
2009-01-08

MICROBICIDAL AGENT AND MICROBICIDAL COMPOSITION

#538
20090010878
2009-01-08

Pulsatile dosing of gossypol for treatment of disease

#539
20080312337
2008-12-18

Anticancer composition comprising obovatol or obovatal

#540
20080274169
2008-11-06

Photosensitizer formulations for topical applications

#541
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#542
20080221497
2008-09-11

Use of Arginine and Like Substances and methylglyoxal and Like Substances in Dialysis Machines

#543
20080221221
2008-09-11

Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization

#544
20080220103
2008-09-11

METHOD FOR TREATING/CONTROLLING/KILLING FUNGI AND BACTERIA ON LIVING ANIMALS

#545
20080161247
2008-07-03

Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH or NADPH dependent enzymes and process thereof

#546
20080145458
2008-06-19

Formulations useful in the treatment of male and female impotence

#547
20080145409
2008-06-19

COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER

#548
20080039531
2008-02-14

Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders

#549
20080026984
2008-01-31

Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

#550
20080004354
2008-01-03

Compositions containing aromatic aldehydes and their use in treatment

#551
20070293585
2007-12-20

Gossypol co-crystals and the use thereof

#552
20070270501
2007-11-22

Medicaments for Treating Barrett's Eesophagus

#553
20070253928
2007-11-01

Pharmaceutical removal of neuronal extensions from a degenerating disc

#554
20070219120
2007-09-20

Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

#555
20070218087
2007-09-20

Method of controlled release of vanillin for nasal and/or pulmonary uptake

#556
20070202143
2007-08-30

Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints

#557
20070196866
2007-08-23

Modulators of ion channel trpa1

#558
20070196351
2007-08-23

Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing

#559
20070128236
2007-06-07

Extraction process

#560
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#561
20070060641
2007-03-15

Therapeutic agent

#562
20070037889
2007-02-15

Anticancer composition comprising obovatol or obovatal

#563
20070036733
2007-02-15

Sensation masking composition

#564
20070031367
2007-02-08

Composition and method for neck skin firming

#565
20060281821
2006-12-14

Retinoid replacements and opsin agonists and methods for the use thereof

#566
20060281813
2006-12-14

Methods of treating hyperproliferative cell disorders

#567
20060276527
2006-12-07

Combination therapies for the treatment of cancer

#568
20060269500
2006-11-30

Topical warming composition

#569
20060241190
2006-10-26

Keratolytic composition with anti-allergic anti-inflammatory properties

#570
20060233771
2006-10-19

Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands

#571
20060229368
2006-10-12

Medical application of oxidized monoterpenes

#572
20060194973
2006-08-31

Trans carotenoids, their synthesis, formulation and uses

#573
20060172953
2006-08-03

Treatment of benign prostatic hyperplasia using energolytic agents

#574
20060127450
2006-06-15

Composition containing higher fatty acid derivative and foods and drinks

#575
20060106366
2006-05-18

Vulnerable plaque treatment

#576
20060104997
2006-05-18

Monoterpene compositions and uses thereof

#577
20060078582
2006-04-13

Use of compositions for treating rosacea

#578
20060057232
2006-03-16

Method of altering age perception

#579
20050288344
2005-12-29

Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

#580
20050274391
2005-12-15

Means for weaning people off smoking and alcohol

#581
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#582
20050234135
2005-10-20

Gossypol co-crystals and the use thereof

#583
20050215649
2005-09-29

Conjugated alphatic dialdehyde disinfecting and sterilizing compositions and methods of using the same

#584
20050203029
2005-09-15

Agents for treating flaviviridaeinfections

#585
20050186265
2005-08-25

Novel cochleate formulations

#586
20050182142
2005-08-18

Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same

#587
20050176678
2005-08-11

Compounds and method for coating surfaces in a haemocompatibe manner

#588
20050175722
2005-08-11

Formulations useful in the treatment of male and female impotence

#589
20050175555
2005-08-11

Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity

#590
20050129724
2005-06-16

Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions

#591
20050070473
2005-03-31

Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof

#592
20050027000
2005-02-03

Methods and compounds useful to induce apoptosis in cancer cells

#593
20050026979
2005-02-03

Methods for treating inflammation and inflammation-associated diseases with a statin and ether

#594
20050026223
2005-02-03

Method and compositions for increasing bone mass

#595
15799573
2019-03-26

Composition and method of using the same

#596
15092597
2016-11-22

Halogenated tetracyclic compounds

#597
14623887
2016-11-15

Methods of treating NFA-1 organism infection using apocynin

#598
12615157
2016-05-31

Malodor eliminating compositions